COCRYSTAL PHARMA, INC. Repayments of Long-Term Debt
COCRYSTAL PHARMA, INC. (COCP) reported Repayments of Long-Term Debt of $23.00 thousand for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2016-11-09
- COCRYSTAL PHARMA, INC. repayments of long-term debt for the quarter ending 2016-09-30 was -$2.00K.
- COCRYSTAL PHARMA, INC. repayments of long-term debt for the quarter ending 2014-12-31 was $0.00.
- COCRYSTAL PHARMA, INC. repayments of long-term debt for the quarter ending 2014-09-30 was -$9.00K.
- COCRYSTAL PHARMA, INC. repayments of long-term debt for the quarter ending 2014-06-30 was -$1.00K.
- COCRYSTAL PHARMA, INC. repayments of long-term debt for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- COCRYSTAL PHARMA, INC. repayments of long-term debt for fiscal 2014 was $3.00K.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month | Repayments of Long-term Debt 12 month as first filed | Repayments of Long-term Debt 87 month |
|---|---|---|---|---|---|---|
| 2016-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $23.00K 10-Q · filed 2016-11-09 | ||||
| 2016-06-30 | $25.00K 10-Q · filed 2016-08-09 | |||||
| 2015-12-31 | $0.00 10-K · filed 2016-03-15 | |||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | -$9.00K derived: sum of 2 quarters · filed 2016-03-15 | -$10.00K derived: sum of 3 quarters · filed 2016-03-15 | $3.00K 10-K · filed 2016-03-15 | -$3.00K 10-K · filed 2015-03-31 | |
| 2014-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | -$10.00K derived: sum of 2 quarters · filed 2015-11-16 | $3.00K 10-Q · filed 2015-11-16 | |||
| 2014-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $12.00K 10-Q · filed 2015-08-14 | ||||
| 2014-03-31 | $13.00K 10-Q · filed 2015-05-14 | $13.00K 10-Q · filed 2014-05-15 | ||||
| 2012-06-30 | $83.58K 10-Q/A · filed 2012-09-28 | |||||
| 2011-06-30 | $137.37K 10-Q/A · filed 2012-09-28 | |||||
| 2010-06-30 | $102.33K 10-Q/A · filed 2011-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |